Maryland State Retirement & Pension System’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,488
Closed -$322K 1455
2025
Q2
$322K Hold
13,488
0.01% 1223
2025
Q1
$335K Sell
13,488
-2,089
-13% -$50K 0.01% 1170
2024
Q4
$293K Hold
15,577
0.01% 1367
2024
Q3
$234K Sell
15,577
-652
-4% -$11.1K ﹤0.01% 1459
2024
Q2
$464K Sell
16,229
-649
-4% -$18.5K 0.01% 1190
2024
Q1
$452K Hold
16,878
0.01% 1184
2023
Q4
$569K Sell
16,878
-219
-1% -$6.41K 0.01% 1052
2023
Q3
$525K Sell
17,097
-820
-5% -$29.6K 0.01% 1020
2023
Q2
$718K Sell
17,917
-560
-3% -$23.2K 0.02% 838
2023
Q1
$754K Sell
18,477
-468
-2% -$18.6K 0.02% 770
2022
Q4
$731K Buy
+18,945
New +$922K 0.02% 732
2022
Q3
Sell
-18,412
Closed -$1.07M 1019
2022
Q2
$1.07M Buy
18,412
+550
+3% +$36K 0.03% 497
2022
Q1
$1.36M Buy
17,862
+104
+0.6% +$6.93K 0.04% 454
2021
Q4
$1.07M Buy
17,758
+248
+1% +$13.7K 0.03% 613
2021
Q3
$998K Buy
+17,510
New +$1.01M 0.03% 617

Other funds holding PCRX

Maryland State Retirement & Pension System's PCRX Position: Q3 2025 in Review

Maryland State Retirement & Pension System sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 13,488 shares — an estimated $322K sold.

Maryland State Retirement & Pension System first reported a position in PCRX in Q3 2021 and held it in 15 quarters. The position peaked at $1.36M in Q1 2022. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

  • Maryland State Retirement & Pension System reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 13,488 Pacira BioSciences shares in Q3 2025, an estimated $322K.
  • Maryland State Retirement & Pension System first reported a position in Pacira BioSciences in Q3 2021 and held it in 15 quarters.
  • Maryland State Retirement & Pension System's Pacira BioSciences position peaked at $1.36M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2025, filed 29 Oct 2025.